Skip to main content
OpenTrials
Completed

NCT Number: NCT02907645

Influenza Vaccine Randomized Educational Trial: Adult

Influenza vaccine is recommended as routine care for all individuals who are at least 6 months of age and older. Recently, questions about vaccine safety and concerns for side effects have increased, contributing to both influenza vaccine hesitancy and refusal. In an effort to educate patients, public health entities and physicians give informational handouts in various forms.

However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. The purpose of this study is to compare the effectiveness of pro-vaccine messages of local data, pro-vaccine messages of national data, and no educational message on patient's receipt of the influenza vaccine. These results will help to understand the relationship between patient education and the intent to vaccinate and receipt of the influenza vaccine as well as to optimize educational information given to patients regarding the influenza vaccine.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Columbia University Medical Center

New York, 10032, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • visit to study site at time of intervention

Exclusion criteria

  • prior receipt of influenza vaccine that season

Treatment and study plan

Local educational information

Behavioral

Adult patients in this arm receive educational information regarding influenza vaccination based on local data

National educational information

Behavioral

Adult patients in this arm receive educational information regarding influenza vaccination based on national data

Primary outcomes

  1. Number of participants who receive influenza vaccination on day of intervention

    Time frame: Day 0

    Receipt of influenza vaccination on the day of the educational intervention

Secondary outcomes

  1. Number of participants who receive Influenza vaccination by the end of the influenza vaccine season

    Time frame: Up to 7 months

    Receipt of influenza vaccination by April 2017

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 20, 2016
Registry last updated
Jul 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.